All lobbying filings

NOVOZYMES NORTH AMERICA, INC.

Lobbying for NOVOZYMES NORTH AMERICA, INC.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · North Carolina · House · Senate · $220,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 3

HR 2756
National Biotechnology Initiative Act of 2025
S 1387
National Biotechnology Initiative Act of 2025
HR 7366
Dietary Supplement Regulatory Uniformity Act

Lobbying activity 3

Environment/Superfund

Issues related to renewables fuels and E-15 - no specific legislation.

Agriculture

Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. H.R. 7366 - Dietary Supplement Regulatory Uniformity Act - Issues related to dietary supplements.

Transportation

Issues pertaining to Supply Chain including movement of containers - no specific legislation. SHIP It Act (not yet introduced) - issues related to tariffs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.